• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性血液透析患者心血管危险因素分析,特别关注高脂蛋白血症。

Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.

作者信息

Hahn R, Oette K, Mondorf H, Finke K, Sieberth H G

出版信息

Atherosclerosis. 1983 Sep;48(3):279-88. doi: 10.1016/0021-9150(83)90045-x.

DOI:10.1016/0021-9150(83)90045-x
PMID:6579964
Abstract

A group of 252 chronic hemodialysis patients was examined for various risk factors. Special emphasis was placed upon the comparison of patients who had marked cardiovascular alterations with the remainder of the group. The seriousness of the risk factors was determine by hypertension and hyperlipoproteinemia, 78% of the patients received antihypertensive medication or had changes in the fundus of the eye or both. In 74% of the patients there were pathological changes in the plasma lipids or lipoproteins or both. Hypertriglyceridemia (49%) and a HDL cholesterol decrease (61%) were the most striking findings. The average VLDL cholesterol value was significantly higher and the HDL cholesterol significantly lower in the coronary heart disease group than in the remaining group. These results show that hyperlipoproteinemia and a decrease in HDL, together with other risk factors such as hypertension and anemia, play an important role in the accelerated development of atherosclerosis in a hemodialysis group.

摘要

对一组252名慢性血液透析患者进行了各种危险因素检查。特别着重比较了有明显心血管改变的患者与该组其他患者。危险因素的严重程度由高血压和高脂蛋白血症决定,78%的患者接受了抗高血压药物治疗,或眼底有改变,或两者皆有。74%的患者血浆脂质或脂蛋白或两者有病理改变。高甘油三酯血症(49%)和高密度脂蛋白胆固醇降低(61%)是最显著的发现。冠心病组的平均极低密度脂蛋白胆固醇值显著高于其余组,而高密度脂蛋白胆固醇则显著低于其余组。这些结果表明,高脂蛋白血症和高密度脂蛋白降低,连同高血压和贫血等其他危险因素,在血液透析组动脉粥样硬化的加速发展中起重要作用。

相似文献

1
Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias.慢性血液透析患者心血管危险因素分析,特别关注高脂蛋白血症。
Atherosclerosis. 1983 Sep;48(3):279-88. doi: 10.1016/0021-9150(83)90045-x.
2
[Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].[高脂蛋白血症、高密度脂蛋白胆固醇与动脉硬化指数]
Z Gesamte Inn Med. 1982 Dec 15;37(24):830-3.
3
[Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].[慢性尿毒症患者血液透析治疗期间血清脂质和脂蛋白水平的变化]
Orv Hetil. 1986 May 11;127(19):1129-31.
4
Serum lipids and lipoproteins in schizophrenic patients with normal renal function treated with hemodialysis.
Artif Organs. 1983 Aug;7(3):353-6. doi: 10.1111/j.1525-1594.1983.tb04210.x.
5
[Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
Pol Arch Med Wewn. 1980 Aug;64(2):161-6.
6
[Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis].[维持性血液透析的慢性肾衰竭患者高密度脂蛋白胆固醇、HDL2和HDL3亚组分以及载脂蛋白A、载脂蛋白A1和载脂蛋白B脂蛋白的变化]
Boll Soc Ital Biol Sper. 1985 Jan 30;61(1):15-21.
7
Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.血清脂蛋白与缺血性血管疾病:关于血清脂质与血清脂蛋白浓度的解读
J Cardiovasc Pharmacol. 1982;4 Suppl 2:S201-5.
8
Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.接受血液透析治疗的慢性肾衰竭患者在无高脂血症情况下的致动脉粥样硬化脂蛋白变化。
Atherosclerosis. 1997 Jun;131(2):229-36. doi: 10.1016/s0021-9150(97)00054-3.
9
[Age-specific features of blood lipid and lipoprotein contents in patients with hypertension].
Ter Arkh. 1980;52(8):11-4.
10
Does atherosclerosis caused by dialysis limit this treatment?透析导致的动脉粥样硬化会限制这种治疗吗?
Proc Eur Dial Transplant Assoc. 1983;19:168-74.

引用本文的文献

1
The lipid story in chronic kidney disease: a long story with a happy end?慢性肾脏病中的脂质故事:一个有美好结局的漫长故事?
Int Urol Nephrol. 2013 Oct;45(5):1273-87. doi: 10.1007/s11255-012-0296-8.
2
Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.慢性血液透析患者血清脂质谱成分作为心血管疾病发病率的标志物
Biomark Insights. 2007 Feb 7;1:185-92.
3
Influence of diabetes on persistent nonhealing ischemic foot ulcer in end-stage renal disease.糖尿病对终末期肾病患者持续性不愈合缺血性足部溃疡的影响。
World J Surg. 2002 Nov;26(11):1360-4. doi: 10.1007/s00268-002-6335-3. Epub 2002 Jul 22.
4
Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure.单核细胞组织因子及黏附分子的表达:与慢性肾衰竭患者冠状动脉疾病加速的关联
Heart. 1999 Feb;81(2):134-40. doi: 10.1136/hrt.81.2.134.
5
Disturbances of lipid metabolism in children with chronic renal failure.慢性肾功能衰竭患儿的脂质代谢紊乱
Pediatr Nephrol. 1993 Dec;7(6):749-57. doi: 10.1007/BF01213345.
6
Changes of serum lipids and lipoproteins during haemodialysis treatment in dialysed chronic uraemic patients.
Int Urol Nephrol. 1986;18(4):463-70. doi: 10.1007/BF02084120.
7
Changes and correlations of antioxidant enzymes, lipid peroxidation and serum neutral lipids due to haemodialysis treatment in chronic uraemic patients.慢性尿毒症患者血液透析治疗后抗氧化酶、脂质过氧化及血清中性脂质的变化与相关性
Int Urol Nephrol. 1988;20(5):559-64. doi: 10.1007/BF02550619.
8
Potential role of carnitine in patients with renal insufficiency.肉碱在肾功能不全患者中的潜在作用。
Klin Wochenschr. 1986 Jul 1;64(13):579-86. doi: 10.1007/BF01735259.
9
[Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].[肾脏疾病中脂质代谢紊乱的病理生理学与治疗]
Klin Wochenschr. 1991 Aug 1;69(11):455-62. doi: 10.1007/BF01649416.